SPARC raises ₹1,112 cr via warrants

Our Bureau Chennai | Updated on July 08, 2021

The committee of board of Sun Pharma Advanced Research Company has approved the allotment of about 6.25 crore warrants on preferential basis at ₹178 each (₹44.50/warrant as subscription price and ₹133.50/warrant as exercise price) to Dilip Shantilal Shanghvi, promoter of the company, and to certain other non-promoter persons/entities. The company has raised ₹1,112.04 crore through warrants. As against the earlier approval for issue of about 6.75 crore warrants, the committee has allotted only about 6.25 crore warrants, due to non-receipt of subscription money by the proposed allottees and/or non- receipt of in-principle approval from the exchanges, it said.

Published on July 08, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like